Valproic
Product Images NDC 17856-4012

5 FDA label images from Atlantic Biologicals Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic (NDC 17856-4012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (17856 4012 01)

Image 1 (17856 4012 01)
Label for Valproic Acid 250 mg capsules, USP, by Atlantic Biologicals Corp. The label includes a barcode, storage instructions for controlled room temperature (59° to 86°F), and a warning to keep out of reach of children. It lists the dosage as 250 mg capsules, quantity 100, with expiration date 02/25/21. The label also provides reorder contact information.*
FDA Label Image

The Following Structural Formula For Valproic Acid (pka 4.8) Has A Molecular Weight Of 144 And Occurs As A Colorless Liquid With A Characteristic Odor. It Is Slightly Soluble In Water (1.3 mg/ml) And Very Soluble In Organic Solvents. (Image 1)

The Following Structural Formula For Valproic Acid (pka 4.8) Has A Molecular Weight Of 144 And Occurs As A Colorless Liquid With A Characteristic Odor. It Is Slightly Soluble In Water (1.3 mg/ml) And Very Soluble In Organic Solvents. (Image 1)
Chemical structure of Valproic acid showing a branched alkyl chain attached to a carboxylic acid functional group. The structure includes two CH3 groups, a CH2 chain, and a carboxyl group (COOH).*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
A line graph comparing the percentage reduction in CPS (complex partial seizures) rate between patients treated with Divalproex Sodium and those given a placebo. The x-axis represents the percentage of patients from 100% to 0%, and the y-axis shows the percentage reduction in CPS rate from -100% to 100%, with indications for improvement, no change, and worsening.*
FDA Label Image

Figure 2 (Image 3)

Figure 2 (Image 3)
A line chart showing the percentage reduction in CPS rate versus the percentage of patients for Valproic, with two lines representing high dose and low dose groups. The vertical axis indicates improvement or worsening in CPS rate, while the horizontal axis shows the percentage of patients.*
FDA Label Image

Image 2 (Valproic Acid)

Image 2 (Valproic Acid)
Label for Valproic acid 250 mg capsules showing expiration date 08/25/2020, manufacturer Catalent Pharma, distributor Atlantic Biologicals, a lot number placeholder, and a barcode. The label states the product is hazardous and lists packaging by UDS.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.